Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

485.20INR
6:28am EDT
Change (% chg)

Rs12.70 (+2.69%)
Prev Close
Rs472.50
Open
Rs477.05
Day's High
Rs486.85
Day's Low
Rs467.80
Volume
1,306,981
Avg. Vol
522,277
52-wk High
Rs818.25
52-wk Low
Rs433.15

Select another date:

Fri, Aug 11 2017

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

BRIEF-Sun Pharma says co on track to achieve $300 mln synergies from Ranbaxy deal

* MD Dilip Shanghvi says on track to achieve $300 million synergies from Ranbaxy deal

BRIEF-Sun Pharmaceutical Industries posts June-qtr consol loss

* June quarter consol net loss 4.25 billion rupees versus profit 20.34 billion rupees last year

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

BRIEF-Sun Pharmaceutical Industries says unit to acquire 15.91 pct diluted stake of Krystal Biotech

* Unit agreed to acquire by way of allotment 203,135 series A preferred stock of Krystal Biotech Inc for $7 million Source text: (http://bit.ly/2vi3zH0) Further company coverage:

BRIEF-Sun Pharmaceutical Industries raises stake in Zenotech

* Raises stake in Zenotech from 46.85 percent of pre rights issue capital to 57.56 percent of post rights issue capital Source text - http://bit.ly/2u1jh7f Further company coverage:

BRIEF-Sun Pharma Advanced Research Co seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc

* Seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc, USA

BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics

* Strategic manufacturing tie-up with Samsung Biologics for Tildrakizumab

BRIEF-Sun Pharma, NIV in pact to test biologic, chemical entities against zika,chikungunya, dengue

* Sun Pharma & NIV sign agreement to fight zika, chikungunya and dengue

BRIEF-Sun Pharma Industries gets members' nod for scheme of arrangement with Sun Pharma Medisales, Ranbaxy Drugs, others

* Gets members' nod for scheme of arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments, co Source text - (http://bit.ly/2tQBUuR) Further company coverage:

Select another date: